[1] Zeng G, Mai Z, Xia S, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study[J]. BJU Int, 2017, 120: 109-116. [2] Scales CD, Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States[J]. Eur Urol, 2012, 62: 160-165. [3] Patel N, Brown RD, Sarkissian C, et al. Quality of life and urolithiasis: the patient-reported outcomes measurement information system (PROMIS)[J]. IBJU, 2017, 43: 880-886. [4] Bryant M, Angell J, Tu H, et al. Health related quality of life for stone formers[J]. J Urol, 2012, 188:436-440. [5] Gambaro G, Favaro S, D'Angelo A. Risk for renal failure in nephrolithiasis[J]. Am J Kidney Dis, 2001, 37: 233-243. [6] Rule AD, Krambeck AE, Lieske JC. Chronic kidney disease in kidney stone formers[J]. Clin J Am Soc Nephrol, 2011, 6: 2069-2075. [7] Sigurjonsdottir VK, Runolfsdottir HL, Indridason OS, et al. Impact of nephrolithiasis on kidney function[J]. BMC Nephrology, 2015, 16: 149-155. [8] Jungers P, Joly D, Barbey F, et al. ESRD caused by nephrolithiasis prevalence, mechanisms, and prevention[J]. Am J Kidney Dis, 2004, 44: 799-805. [9] Rule AD, Bergstralh EJ, Melton LJ, et al. Kidney stones and the risk for chronic kidney disease[J]. Clin J Am Soc Nephro, 2009, 4: 11-804. [10] Vupputuri S, Soucie JM, McClellan W, et al. History of kidney stones as a possible risk factor for chronic kidney disease[J]. Ann Epidemiol, 2004, 14: 222-228. [11] Gambaro G, Croppi E, Bushinsky D, et al. The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review[J]. J Urol, 2017, 198: 268-273. [12] Gambaro G, Croppi E, Coe F, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement[J]. J Nephrol, 2016, 29: 715-734. [13] Inci M, Demirtas A, Sarli B, et al. Association between body mass nidex, lipid profiles, and types of urinary stones[J]. Ren Fail, 2012, 34: 1140-1143. [14] Kang HW, Seo SP, Kim WT, et al. Hypertriglyceridemia is associated with increased risk for stone recurrence in patients with urolithiasis[J]. Urology, 2014, 84: 766-771. [15] Chu FY, Chang CC, Huang PH, et al. The association of uric acid calculi with obesity, prediabetes, type 2 diabe-tes mellitus, and hypertension[J]. Biomed Res Int, 2017.doi:org/10.1155/2017/7523960. [16] Li CC, Chien TM, Wu WJ, et al. Uric acid stones increase the risk of chronic kidney disease[J]. Urolithiasis, 2018, 46: 543-547. [17] Moreira DM, Friedlander JI, Hartman C, et al. Associa-tion of estimated glomerular filtration rate with 24h urinalysis and stone composition[J]. Urolithiasis, 2016, 44: 319-325. [18] Nassir A, Saada H, Alnajjar T, et al. The impact of stone composition on renal function[J]. Urol Ann, 2018, 10: 215-218. [19] Hommos MS, Glassock RJ, Rule AD. Structural and functional changes in human kidnay with healthy aging [J]. J Am Soc Nephrol, 2017, 28: 2838-2844. |